INIS
data
41%
populations
31%
levels
24%
brain
23%
glucose
23%
risks
22%
diseases
22%
obesity
19%
nervous system diseases
18%
netherlands
17%
comparative evaluations
17%
environment
15%
metabolism
14%
food
14%
plasma
14%
intake
12%
sex
11%
incidents
10%
performance
10%
volume
10%
people
10%
men
10%
vessels
9%
diet
9%
methylation
9%
biological markers
9%
damage
9%
tissues
9%
diabetes mellitus
9%
nerves
9%
prediction
9%
layers
8%
learning
8%
dna
8%
women
8%
insulin
8%
concentration
8%
liver
7%
sulfur
7%
amino acids
7%
humans
7%
nmr imaging
7%
tools
6%
education
6%
sensitivity
6%
precision
6%
range
6%
quality of life
5%
patients
5%
interactions
5%
cysteine
5%
adjustments
5%
fibers
5%
skin
5%
thickness
5%
fats
5%
hazards
5%
regression analysis
5%
Keyphrases
Maastricht
100%
Type 2 Diabetes Mellitus (T2DM)
49%
Pre-diabetes (pre-DM)
22%
Netherlands
19%
Obesity
17%
Dementia
16%
Food Environment
12%
Neurodegeneration
11%
Socioeconomic Position
11%
Cognitive Functioning
9%
Glucose Metabolism Status
8%
Normal Glucose Tolerance
8%
Habitual Intake
8%
Multi-cohort
8%
Structural Brain Damage
8%
Social Cohesion
8%
DNA Methylation (DNAm)
8%
Sulfur Amino Acids
7%
Cognitive Performance
7%
Population-based Cohort
7%
Diet Quality
7%
Non-associated
6%
Cognitive Function
6%
Dementia Research
6%
Cardiometabolic Disease
6%
Cerebral Small Vessel Disease (cSVD)
6%
Mediating Role
6%
Body Mass Index
6%
Advanced Glycation End Products
6%
Quality of Life
5%
Insulin Sensitivity
5%
Inner Retinal Layers
5%
Peripheral Tissues
5%
Left-handedness
5%
Data Harmonization
5%
Federated Learning
5%
Observational Medical Outcomes Partnership
5%
Brain Connectivity
5%
Structural Brain Connectivity
5%
Precision Prediction
5%
Subclassification
5%
Patient Health Questionnaire-9 (PHQ-9)
5%
Cohort Consortium
5%
Diabetes
5%
Meta-analysis
5%
Total Cysteine
5%
Walkability
5%
Neighborhood Walkability
5%
Gray Matter Volume
5%
Low Socioeconomic Status
5%
Confidence Interval
5%
Individual Participant Data Meta-analysis
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
26%
Impaired Glucose Tolerance
19%
Glucose Metabolism
15%
Neurodegeneration
10%
Meta-Analysis
10%
Biological Marker
9%
Cohort Analysis
8%
Diabetes
6%
Diseases
6%
Fatty Liver
6%
Sulfur Amino Acid
5%
Beta Cell
5%
Quality of Life
5%
Insulin Sensitivity
5%
Gray Matter
5%
Alzheimer's Disease
5%
Corneal Nerve
5%
Advanced Glycation End-Product
5%
Retinal Nerve Fiber Layer
5%
Particular Matter 2.5
5%